BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 32816199)

  • 1. Positive predictive value for malignancy of uncertain malignant potential (B3) breast lesions diagnosed on vacuum-assisted biopsy (VAB): is surgical excision still recommended?
    Lucioni M; Rossi C; Lomoro P; Ballati F; Fanizza M; Ferrari A; Garcia-Etienne CA; Boveri E; Meloni G; Sommaruga MG; Ferraris E; Lasagna A; Bonzano E; Paulli M; Sgarella A; Di Giulio G
    Eur Radiol; 2021 Feb; 31(2):920-927. PubMed ID: 32816199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lesions of uncertain malignant potential of the breast (B3) on vacuum-assisted biopsy for microcalcifications: Predictors of malignancy.
    Mariscotti G; Durando M; Ruggirello I; Belli P; Caumo F; Nori J; Zuiani C; Tagliafico A; Bicchierai G; Romanucci G; Londero V; Campanino PP; Bussone R; Castellano I; Mule' A; Caneva A; Bianchi S; Di Loreto C; Bergamasco L; Calabrese M; Fonio P; Houssami N
    Eur J Radiol; 2020 Sep; 130():109194. PubMed ID: 32795765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-risk lesions diagnosed at MRI-guided vacuum-assisted breast biopsy: imaging characteristics, outcome of surgical excision or imaging follow-up.
    Okamoto S; Chen ST; Covelli JD; DeMartini WB; Daniel BL; Ikeda DM
    Breast Cancer; 2020 May; 27(3):405-414. PubMed ID: 31838725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Third International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions).
    Elfgen C; Leo C; Kubik-Huch RA; Muenst S; Schmidt N; Quinn C; McNally S; van Diest PJ; Mann RM; Bago-Horvath Z; Bernathova M; Regitnig P; Fuchsjäger M; Schwegler-Guggemos D; Maranta M; Zehbe S; Tausch C; Güth U; Fallenberg EM; Schrading S; Kothari A; Sonnenschein M; Kampmann G; Kulka J; Tille JC; Körner M; Decker T; Lax SF; Daniaux M; Bjelic-Radisic V; Kacerovsky-Strobl S; Condorelli R; Gnant M; Varga Z
    Virchows Arch; 2023 Jul; 483(1):5-20. PubMed ID: 37330436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The positive predictive value of vacuum assisted biopsy (VAB) in predicting final histological diagnosis for breast lesions of uncertain malignancy (B3 lesions): A systematic review & meta-analysis.
    Cullinane C; Byrne J; Kelly L; O Sullivan M; Antony Corrigan M; Paul Redmond H
    Eur J Surg Oncol; 2022 Jul; 48(7):1464-1474. PubMed ID: 35491362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Upgrade Risk of B3 Lesions to (Pre)Invasive Breast Cancer After Diagnosis on Core Needle or Vacuum Assisted Biopsy. A Belgian National Cohort Study.
    Willers N; Neven P; Floris G; Colpaert C; Oldenburger E; Han S; Van Ongeval C; Smeets A; Duhoux FP; Wildiers H; Denolf P; Laudus N; Dequeker E; De Brabander I; Van Damme N; De Schutter H
    Clin Breast Cancer; 2023 Jun; 23(4):e273-e280. PubMed ID: 37085379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of vacuum assisted excision in minimising overtreatment of ductal atypias.
    McMahon MA; Haigh I; Chen Y; Millican-Slater RA; Sharma N
    Eur J Radiol; 2020 Oct; 131():109258. PubMed ID: 32919262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions).
    Rageth CJ; O'Flynn EA; Comstock C; Kurtz C; Kubik R; Madjar H; Lepori D; Kampmann G; Mundinger A; Baege A; Decker T; Hosch S; Tausch C; Delaloye JF; Morris E; Varga Z
    Breast Cancer Res Treat; 2016 Sep; 159(2):203-13. PubMed ID: 27522516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of epithelial atypia in B3-lesions of the breast is associated with decreased risk for malignancy.
    Mayer S; Kayser G; Rücker G; Bögner D; Hirschfeld M; Hug C; Stickeler E; Gitsch G; Erbes T
    Breast; 2017 Feb; 31():144-149. PubMed ID: 27866089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of high-risk breast lesions diagnosed using image-guided core needle biopsy: results from a multicenter retrospective study.
    Oktay A; Aslan Ö; Taşkın F; Tunçbilek N; Esen İçten SG; Balcı P; Arıbal ME; Çelik L; Örgüç İŞ; Başaran Demirkazık F; Gültekin S; Aydın AM; Durmaz E; Kul S; Binokay F; Çetin M; Emlik GD; Akpınar MG; Kadıoğlu Voyvoda SN; Polat AV; Başara Akın I; Yıldız Ş; Poyraz N; Özsoy A; Öztekin PS; Elverici E; Bayrak İK; İkizceli T; Dinç F; Sezgin G; Gülşen G; Tunçbilek I; Yalçın SR; Çolakoğlu G; Ağlamış S; Yılmaz R; Rona G; Durhan G; Güner DC; Çelik Yabul F; Günbey Karabekmez L; Tutar B; Göktaş M; Buğdaycı O; Suner A; Özdemirhttps/Orcid Org/ N
    Diagn Interv Radiol; 2023 Jul; 29(4):579-587. PubMed ID: 36994925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. All pure flat atypical atypia lesions of the breast diagnosed using percutaneous vacuum-assisted breast biopsy do not need surgical excision.
    Ouldamer L; Poisson E; Arbion F; Bonneau C; Vildé A; Body G; Michenet P
    Breast; 2018 Aug; 40():4-9. PubMed ID: 29665448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of Long-term Follow-up in Surgically Excised Lesions of Uncertain Malignant Potential in the Breast - Is 5 Years Necessary?
    Hennessy G; Boland MR; Bambrick M; Crone L; Lloyd A; Abdelwahab S; Downey E; Staunton M; Hambly N; Mhuircheartaigh NN; Kerr J; Power C; Duke D; Hill AD
    Clin Breast Cancer; 2022 Oct; 22(7):699-704. PubMed ID: 35732544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions).
    Rageth CJ; O'Flynn EAM; Pinker K; Kubik-Huch RA; Mundinger A; Decker T; Tausch C; Dammann F; Baltzer PA; Fallenberg EM; Foschini MP; Dellas S; Knauer M; Malhaire C; Sonnenschein M; Boos A; Morris E; Varga Z
    Breast Cancer Res Treat; 2019 Apr; 174(2):279-296. PubMed ID: 30506111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flat epithelial atypia: are we being too aggressive?
    DiPasquale A; Silverman S; Farag E; Peiris L
    Breast Cancer Res Treat; 2020 Jan; 179(2):511-517. PubMed ID: 31701300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B3 lesion upgrade rates in a tertiary Australian breast centre: a 8-year experience (2012-2019).
    Huang YY; Park H; McLaren S; Thirunavukkarasu P; Lin JTW; Rajakaruna R; Dhillon R; Ponniah AK
    ANZ J Surg; 2020 Dec; 90(12):2521-2526. PubMed ID: 32969161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lesions of "uncertain malignant potential" in the breast (B3) identified with mammography screening.
    Richter-Ehrenstein C; Maak K; Röger S; Ehrenstein T
    BMC Cancer; 2018 Aug; 18(1):829. PubMed ID: 30115017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignancy rates of B3-lesions in breast magnetic resonance imaging - do all lesions have to be excised?
    Preibsch H; Wanner LK; Staebler A; Hahn M; Siegmann-Luz KC
    BMC Med Imaging; 2018 Sep; 18(1):27. PubMed ID: 30200900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical excision for B3 breast lesions diagnosed by vacuum-assisted core biopsy.
    Reefy S; Osman H; Chao C; Perry N; Mokbel K
    Anticancer Res; 2010 Jun; 30(6):2287-90. PubMed ID: 20651381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An audit of mammographic screen detected lesions of uncertain malignant potential (B3) diagnosed on initial image guided needle biopsy: how has our practice changed over 10 years?
    Batohi B; Fang C; Michell MJ; Morel J; Shah C; Wijesuriya S; Peacock C; Rahim R; Wasan R; Goligher J; Satchithananda K
    Clin Radiol; 2019 Aug; 74(8):653.e19-653.e25. PubMed ID: 31078275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upgrade rate to malignancy of uncertain malignant potential breast lesions (B3 lesions) diagnosed on vacuum-assisted biopsy (VAB) in screen detected microcalcifications: Analysis of 366 cases from a single institution.
    Bianchi S; Caini S; Vezzosi V; Orzalesi L; Piovesan L; Mantellini P; Ambrogetti D
    Eur J Radiol; 2024 Jan; 170():111258. PubMed ID: 38091661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.